Mercado de plásticos médicos: mapeo competitivo y perspectivas estratégicas para 2031

  • Report Code : TIPRE00009963
  • Category : Chemicals and Materials
  • Status : Published
  • No. of Pages : 153
Buy Now

El mercado de plásticos médicos fue valorado en 24.671,82 millones de dólares en 2019 y se prevé que alcance los 44.669,63 millones de dólares en 2027; se espera que crezca a una tasa compuesta anual del 7,7 % entre 2020 y 2027.

Los plásticos médicos están hechos de una gran cantidad de macromoléculas. Estos plásticos se utilizan para producir instrumentos consistentes y seguros en la industria de la salud. Son notablemente duraderos, flexibles y económicos. El rendimiento, la esterilidad y la calidad de los dispositivos médicos son un factor importante para la expansión del mercado. Los plásticos médicos encuentran una amplia gama de aplicaciones en instrumentos de diagnóstico, implantes, desechables, dispositivos de administración de medicamentos, instrumentos quirúrgicos, jeringas y catéteres. Se prevé que la población mundial aumentará en los próximos años. Con el aumento de la población, las enfermedades e infecciones se están propagando desenfrenadamente a través de varios medios. El aumento de la población geriátrica mejora aún más el desarrollo del sector sanitario.

Se espera que el mercado mundial de plásticos médicos en Asia Pacífico crezca a la tasa compuesta anual más alta del 8,4 % durante 2020. ;2027. El rápido crecimiento del mercado en esta región se atribuye principalmente a la creciente demanda de plásticos médicos debido a sus aplicaciones en desechables médicos, prótesis, instrumentos y herramientas médicos y administración de medicamentos.

El reciente brote de COVID-19, que comenzó en Wuhan, China, en diciembre de 2019, se ha extendido por todo el mundo a un ritmo rápido. En junio de 2020, Estados Unidos, Rusia, India, China, Italia, Francia y Alemania se encuentran entre los países más afectados en términos de casos positivos y muertes reportadas. Según las cifras de la OMS actualizadas en junio de 2020, se han notificado ~7.482.952 casos confirmados y ~419.497 muertes en todo el mundo. El brote ha afectado a las economías y las industrias debido a los cierres, prohibiciones de viaje y cierres de empresas convocados en varios países. Los productos químicos y materiales son una de las principales industrias del mundo. Está sufriendo graves perturbaciones, como interrupciones en la cadena de suministro, cancelaciones de eventos tecnológicos y cierres de oficinas, como resultado de este brote. China es el centro de fabricación mundial y el mayor proveedor de materias primas para diversas industrias. La suspensión de varias plantas y fábricas en China está afectando las cadenas de suministro globales y afectando negativamente la fabricación y venta de diversos productos químicos y materiales. El colapso general del mercado debido a la pandemia de COVID-19 también está afectando el crecimiento del mercado mundial de plásticos médicos.

Perspectivas estratégicas

Mercado global de plásticos médicos


Perspectivas del mercado

Numerosas ventajas que ofrecen los plásticos en dispositivos médicos favorecen el crecimiento del mercado a nivel mundial

Las jeringas de plástico desechables, las nuevas válvulas cardíacas, las bolsas de sangre y varios dispositivos médicos están hechos de material plástico. Para competir con las crecientes preocupaciones con respecto al estafilococo aureus resistente a la meticilina y se han desarrollado polímeros de alta tecnología, infecciones por estafilococos de transmisión hospitalaria y plásticos antimicrobianos. Estos plásticos repelen y matan la mayoría de las bacterias, incluso en superficies de mucho contacto, y previenen infecciones. Además, los plásticos antimicrobianos tienen una eficacia muy alta para matar bacterias incluso cuando las superficies no se limpian con regularidad. De esta manera, el uso de polímeros de alta tecnología y plásticos antimicrobianos en dispositivos médicos ayuda a reducir el riesgo de enfermedades para los pacientes. Debido a su alta resistencia al impacto y estabilidad térmica, los plásticos de ingeniería están reemplazando ampliamente a la madera o cualquier otro material utilizado como mango para instrumentos quirúrgicos. Además, los plásticos necesitan menos mantenimiento y esterilización menos frecuente. Los fabricantes están pasando de la madera y el metal a los plásticos de ingeniería como el POM debido a su rendimiento superior, bajo precio, propiedades no higroscópicas y buena maquinabilidad.

Información sobre aplicaciones< /p>

Según la aplicación, el mercado de plásticos médicos se segmenta en desechables médicos, prótesis, instrumentos y herramientas médicos, administración de medicamentos y otros. El segmento de instrumentos y herramientas médicos representó la mayor parte del mercado mundial en 2019. Los plásticos se han utilizado ampliamente para crear herramientas e instrumentos médicos, como jeringas, guantes quirúrgicos, plumas de insulina, catéteres, tubos intravenosos y fracturas inflables. Estos productos se fabrican para un solo uso y ayudan a evitar la propagación de enfermedades peligrosas al eliminar la necesidad de reutilizar o esterilizar un dispositivo. Los plásticos también se utilizan para crear superficies táctiles antimicrobianas superiores que pueden repeler microbios y otras bacterias, disminuyendo así la propagación de enfermedades peligrosas.

Mercado mundial de plásticos médicos: por aplicación, 2019 y 2027


Mercado de plásticos médicos, por tipo

  • Plásticos estándar < /li>
  • Plásticos para ingeniería
  • Plásticos de alto rendimiento (HPP)
  • Silicona
  • Otros

Plásticos médicos Mercado, por aplicación

  • Desechables médicos
  • Prótesis
  • Instrumentos y herramientas médicos
  • Administración de medicamentos
  • Otros

Perfiles de empresas

  • Celanese Corporation
  • Eastman Chemical Company
  • GW Plastics
  • Orthoplastics Ltd
  • ARAN BIOMÉDICA TEORANTA
  • Rochling
  • SABIC
  • Saint-Gobain
  • Solvay
  • Dow
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Based on application, why is the medical disposables segment expected to grow at the highest rate during 2020–2027?

The demand for several types for medical disposables for treatment and diagnosis purpose is increasing owing to cost-effectiveness and production efficiency. The demand has also upstaged as it reduces the risk of cross-contamination and infection to patients. Wound management products, diagnostic and laboratory disposables, dialysis disposables, incontinence products, respiratory supplies, sterilization supplies, non-woven disposables, disposable masks, disposable eye gear, disposable gloves are some of the medical disposable extensively used in the healthcare industry.

Can you list some of the major players operating in the global medical plastics market?

Celanese Corporation, Eastman Chemical Company, GW Plastics, Orthoplastics Ltd, ARAN BIOMEDICAL TEORANTA, Rochling, SABIC, Saint-Gobain, Solvay, and Dow are among the major players in the global medical plastics market.

Which region held the largest share of the global medical plastics market?

In 2019, the medical plastic market was predominant in North America at the global level. North America is an attractive market categorized by the increasing demand for medical plastics. The growing innovations for the application of medical plastic backed by purchasing power to buy high priced medical plastic is positively impacting the growth of medical plastics market.

The List of Companies - Fresh Pear Market

  1. Celanese Corporation
  2. Eastman Chemical Company
  3. GW Plastics
  4. Orthoplastics Ltd
  5. ARAN BIOMEDICAL TEORANTA
  6. Rochling
  7. SABIC
  8. Saint-Gobain
  9. Solvay
  10. Dow

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports